F10 and COVID-19: Moreover, all these mitochondrial effects associated with the presence of COVID-19 spike subunits were inhibited by the FXa inhibitor rivaroxaban, suggesting the involvement of endogenous FXa in the mitochondrial effects elicited by the COVID-19 spike subunits.